See more : Orpea SA (ORP.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Asarina Pharma AB (publ) (ASRPF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Asarina Pharma AB (publ), a leading company in the industry within the sector.
You may be interested
- Amniotics AB (publ) (AMNI.ST) Income Statement Analysis – Financial Results
- Kesla Oyj (KELAS.HE) Income Statement Analysis – Financial Results
- Spire Global, Inc. (SPIR-WT) Income Statement Analysis – Financial Results
- SIMPPLE LTD. Ordinary Shares (SPPL) Income Statement Analysis – Financial Results
- First Gen Corporation (FSGCY) Income Statement Analysis – Financial Results
Asarina Pharma AB (publ) (ASRPF)
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23.09M | 39.38M | 17.50M | 6.61M | 4.77M | 3.10M | 3.20M | 3.13M | 1.86M | 2.50M |
| Cost of Revenue | 12.80M | 30.18M | 12.52M | 3.23M | 2.12M | 1.39M | 1.14M | 1.11M | 1.16M | 1.79M |
| Gross Profit | 10.29M | 9.20M | 4.98M | 3.38M | 2.65M | 1.71M | 2.06M | 2.02M | 698.30K | 710.94K |
| Gross Profit Ratio | 44.57% | 23.36% | 28.47% | 51.12% | 55.58% | 55.20% | 64.29% | 64.54% | 37.60% | 28.39% |
| Research & Development | 1.34M | 877.61K | 1.14M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.35M | 1.05M | 877.71K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 3.96M | 3.58M | 1.89M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 5.31M | 4.63M | 2.76M | 2.75M | 2.35M | 1.62M | 1.52M | 1.42M | 1.41M | 1.10M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 6.62M | 5.47M | 3.86M | 3.09M | 2.79M | 1.77M | 1.69M | 1.56M | 1.59M | 1.50M |
| Cost & Expenses | 19.41M | 35.65M | 16.37M | 6.32M | 4.91M | 3.16M | 2.83M | 2.67M | 2.75M | 3.29M |
| Interest Income | 210.59K | 276.23K | 107.44K | 39.62K | 8.53K | 194.56 | 834.50 | 48.97K | 37.99K | 85.80K |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 328.63K | 163.20K | 492.77K | 221.76K | 306.00K | 110.22K | 121.73K | 108.53K | 67.47K | 85.30K |
| EBITDA | 4.00M | 3.90M | 1.62M | 637.50K | 252.30K | 87.07K | 491.94K | 563.47K | -738.75K | -403.63K |
| EBITDA Ratio | 17.33% | 9.89% | 9.25% | 9.65% | 5.29% | 2.81% | 15.38% | 18.01% | -39.78% | -16.12% |
| Operating Income | 3.67M | 3.73M | 1.13M | 415.74K | -53.70K | -23.15K | 370.21K | 454.94K | -806.22K | -488.93K |
| Operating Income Ratio | 15.90% | 9.48% | 6.43% | 6.29% | -1.13% | -0.75% | 11.57% | 14.54% | -43.41% | -19.52% |
| Total Other Income/Expenses | -210.59K | -276.13K | -107.44K | -165.91K | -91.39K | -35.22K | -834.00 | -48.97K | -121.33K | -381.91K |
| Income Before Tax | 3.46M | 3.46M | 1.02M | 249.83K | -145.09K | -58.37K | 369.37K | 405.97K | -927.55K | -870.84K |
| Income Before Tax Ratio | 14.99% | 8.78% | 5.82% | 3.78% | -3.04% | -1.88% | 11.55% | 12.98% | -49.95% | -34.77% |
| Income Tax Expense | 714.72K | 424.53K | 5.37K | 1.56K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 2.75M | 3.03M | 1.01M | 248.27K | -145.09K | -58.37K | 369.37K | 405.97K | -927.55K | -870.84K |
| Net Income Ratio | 11.90% | 7.70% | 5.79% | 3.76% | -3.04% | -1.88% | 11.55% | 12.98% | -49.95% | -34.77% |
| EPS | 0.09 | 0.10 | 0.03 | 0.01 | 0.00 | 0.00 | 0.01 | 0.02 | -0.06 | -0.06 |
| EPS Diluted | 0.09 | 0.10 | 0.03 | 0.01 | 0.00 | 0.00 | 0.01 | 0.02 | -0.06 | -0.06 |
| Weighted Avg Shares Out | 29.53M | 29.06M | 29.06M | 30.08M | 30.26M | 25.80M | 25.29M | 23.26M | 16.27M | 13.53M |
| Weighted Avg Shares Out (Dil) | 29.73M | 29.06M | 29.06M | 30.08M | 30.26M | 25.80M | 25.29M | 23.26M | 16.27M | 13.53M |
No news found for: ASRPF
Source: https://incomestatements.info
Category: Stock Reports